東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Fatty liver." ]

切換: 標籤 | MARC模式 | ISBD

Non-alcoholic fatty liver disease = ...

Bugianesi, Elisabetta.

FindBook

Google Book

Amazon

博客來

Non-alcoholic fatty liver disease = a 360-degree overview /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Non-alcoholic fatty liver disease/ edited by Elisabetta Bugianesi.
其他題名:	a 360-degree overview /
其他作者:	Bugianesi, Elisabetta.
出版者:	Cham :Springer International Publishing : : 2020.,
面頁冊數:	x, 362 p. :ill., digital ;24 cm.
內容註:	Introduction -- Obesity and NAFLD: same problem? The burden of NAFLD worldwide -- Histo-pathology of NAFLD -- NAFLD and insulin resistance: a multisystemic -- Etiopathogenesis of NAFLD: diet, gut and NASH -- Etiopathogenesis of NAFLD: molecular mechanisms of fibrogenesis -- The natural history of NAFLD: Environmental vs Genetic Risk Factors -- NAFLD and endocrine disease: clinical implications -- NAFLD and Cardiovascular Disease: clinical implications -- NAFLD, Hepatocellular Carcinoma and extrahepatic cancers -- NAFLD in children: implications for the future -- Diagnostic algorithm for the identification of NAFLD in primary care -- Non-Invasive diagnostic approach to NASH: Biological Markers -- Non-Invasive diagnostic approach to NASH: Radiological Diagnostics -- Dietary approach to NAFLD -- Physical Activity in NAFLD: what and how much? Pharmacological Therapy of NASH -- Bariatric Surgery and NASH: a feasible option? Liver transplantation and NASH -- Unmet needs and future goals.
Contained By:	Springer Nature eBook
標題:	Fatty liver. -
電子資源:	https://doi.org/10.1007/978-3-319-95828-6
ISBN:	9783319958286

Non-alcoholic fatty liver disease = a 360-degree overview /
Non-alcoholic fatty liver diseasea 360-degree overview /[electronic resource] :edited by Elisabetta Bugianesi. - Cham :Springer International Publishing :2020. - x, 362 p. :ill., digital ;24 cm.

Introduction -- Obesity and NAFLD: same problem? The burden of NAFLD worldwide -- Histo-pathology of NAFLD -- NAFLD and insulin resistance: a multisystemic -- Etiopathogenesis of NAFLD: diet, gut and NASH -- Etiopathogenesis of NAFLD: molecular mechanisms of fibrogenesis -- The natural history of NAFLD: Environmental vs Genetic Risk Factors -- NAFLD and endocrine disease: clinical implications -- NAFLD and Cardiovascular Disease: clinical implications -- NAFLD, Hepatocellular Carcinoma and extrahepatic cancers -- NAFLD in children: implications for the future -- Diagnostic algorithm for the identification of NAFLD in primary care -- Non-Invasive diagnostic approach to NASH: Biological Markers -- Non-Invasive diagnostic approach to NASH: Radiological Diagnostics -- Dietary approach to NAFLD -- Physical Activity in NAFLD: what and how much? Pharmacological Therapy of NASH -- Bariatric Surgery and NASH: a feasible option? Liver transplantation and NASH -- Unmet needs and future goals.

The goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) - which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia - and to share the latest information on evolving approaches to diagnosis and treatment. The book offers a comprehensive overview of the current topics of interest in the field, and provides clinical guidance on NAFLD through a multidisciplinary approach based on the latest scientific understanding of this multisystemic disease, involving the expertise of specialists including hepatologists, diabetologists, and cardiologists. The respective contributions address various aspects, including the newly released international guidelines, novel diagnostic modalities, and new experimental drugs. The work will appeal to a broad readership, from residents in internal medicine to specialists.

ISBN: 9783319958286

Standard No.: 10.1007/978-3-319-95828-6doiSubjects--Topical Terms:

2181360
Fatty liver.

LC Class. No.: RC848.F3 / N66 2020

Dewey Class. No.: 616.362

Non-alcoholic fatty liver disease = a 360-degree overview /
LDR:02894nmm a2200325 a 4500 001 2243936
003 DE-He213
005 20210128155848.0
006 m d
007 cr nn 008maaau
008 211207s2020 sz s 0 eng d
020 $a 9783319958286 $q (electronic bk.)
020 $a 9783319958279 $q (paper)
024 7 $a 10.1007/978-3-319-95828-6 $2 doi
035 $a 978-3-319-95828-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.F3 $b N66 2020
072 7 $a MJJ $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJJ $2 thema
082 0 4 $a 616.362 $2 23
090 $a RC848.F3 $b N812 2020
245 0 0 $a Non-alcoholic fatty liver disease $h [electronic resource] : $b a 360-degree overview / $c edited by Elisabetta Bugianesi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a x, 362 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- Obesity and NAFLD: same problem? The burden of NAFLD worldwide -- Histo-pathology of NAFLD -- NAFLD and insulin resistance: a multisystemic -- Etiopathogenesis of NAFLD: diet, gut and NASH -- Etiopathogenesis of NAFLD: molecular mechanisms of fibrogenesis -- The natural history of NAFLD: Environmental vs Genetic Risk Factors -- NAFLD and endocrine disease: clinical implications -- NAFLD and Cardiovascular Disease: clinical implications -- NAFLD, Hepatocellular Carcinoma and extrahepatic cancers -- NAFLD in children: implications for the future -- Diagnostic algorithm for the identification of NAFLD in primary care -- Non-Invasive diagnostic approach to NASH: Biological Markers -- Non-Invasive diagnostic approach to NASH: Radiological Diagnostics -- Dietary approach to NAFLD -- Physical Activity in NAFLD: what and how much? Pharmacological Therapy of NASH -- Bariatric Surgery and NASH: a feasible option? Liver transplantation and NASH -- Unmet needs and future goals.
520 $a The goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) - which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia - and to share the latest information on evolving approaches to diagnosis and treatment. The book offers a comprehensive overview of the current topics of interest in the field, and provides clinical guidance on NAFLD through a multidisciplinary approach based on the latest scientific understanding of this multisystemic disease, involving the expertise of specialists including hepatologists, diabetologists, and cardiologists. The respective contributions address various aspects, including the newly released international guidelines, novel diagnostic modalities, and new experimental drugs. The work will appeal to a broad readership, from residents in internal medicine to specialists.
650 0 $a Fatty liver. $3 2181360
650 0 $a Hepatology. $3 894467
650 0 $a Endocrinology. $3 610914
650 0 $a Cardiology. $3 861477
700 1 $a Bugianesi, Elisabetta. $3 3504419
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-319-95828-6
950 $a Medicine (SpringerNature-11650)